Background-The atheroprotective effect of 17␤-estradiol (E 2 ) has been suggested in women and clearly demonstrated in animals through both an effect on lipid metabolism and a direct effect on the cells of the arterial wall. It has been shown, for example, that E 2 promotes endothelium-dependent relaxation and accelerates reendothelialization in rats. Similar studies have been undertaken in mice to appreciate the molecular mechanism of this process. Methods and Results-We report here a model of electric carotid injury adapted from that described by Carmeliet et al (1997) that allows us to precisely evaluate the reendothelialization process. We demonstrate that E 2 accelerates endothelial regeneration in castrated female wild-type mice. In ovariectomized transgenic mice in which either the estrogen receptor (ER)-␣ or ER␤ gene has been disrupted, E 2 accelerated reendothelialization in female ER␤ knockout mice, whereas this effect was abolished in female ER␣ knockout mice. Conclusions-This study demonstrates that ER␣ but not ER␤ mediates the beneficial effect of E 2 on reendothelialization and potentially the prevention of atherosclerosis. (Circulation. 2001;103:423-428.)
vasculoprotective effect of estrogens. This is traditionally thought to be due to potentially favorable changes in blood lipids and lipoproteins, 3 but a number of experimental studies 4 -9 strongly suggest a direct effect on the vascular system. Among the cell types present in the normal and atherosclerotic vessel wall, endothelium represents both a key actor in the pathophysiology of atherosclerosis and an important target for 17␤-estradiol (E 2 ).
Twenty years of intensive experimental work has confirmed the crucial role of endothelium in the physiology of circulation. The endothelium is uniquely positioned at the interface between the blood and the vessel wall. As such, it performs multiple functions: it is involved in the regulation of coagulation, leukocyte adhesion in inflammation, vessel tone, and vascular smooth muscle growth and also acts as a barrier to transvascular flux of liquids and solutes. In addition, endothelial abnormalities appear to be central to the pathogenesis of atherosclerosis. 10, 11 The importance of endothelial integrity was initially demonstrated by the facilitation of atherosclerotic lesion development in hypercholesterolemic animal models after removal of endothelium. Although subsequent studies demonstrated the presence of endothelium overlying the lesions, repeated mechanical, hemodynamic, and/or immunological injury probably contributes to morpho-logical and functional alterations of the endothelium as well as its senescence. Telomere length is decreased in cells of the arterial tree subject to hemodynamic stress and prone to atherosclerosis, demonstrating an accelerated cell turnover at these sites. 12 Recent experimental work has demonstrated that low shear stress, which in some respects mimics turbulent blood flow, favors apoptosis of cultured endothelial cells. 13, 14 Altogether, these observations suggest that the capacity of endothelium to maintain a cell monolayer could be of crucial importance in the prevention of atherosclerosis and its complications.
Several models of arterial injury have been developed to study endothelial regrowth. Injury of an artery by passage of a balloon catheter causes endothelial denudation and medial damage and produces both an endothelial and a smooth muscle cell proliferative response in nonhuman primates, swine, dogs, rabbits, and rats. 15 In such models, E 2 was reported to promote endothelial regrowth in castrated female rats. 16 The effect of E 2 has long been thought to be mediated through activation of the estrogen receptor (ER)-␣. ER␣ is a ligand-dependent transcriptional activator 17 that modulates gene expression in target cells not only in reproductive tissues but also in bone and vessels. 18, 19 Moreover, ER␤, recently discovered and cloned from rat prostate, 20 was found to be expressed in many other tissues, including injured arteries. 21, 22 Evaluation of the respective roles of ER␣ and ER␤ in the reendothelialization process requires a reliable model of mouse arterial injury in which the extent of endothelial regrowth can be quantified. Removal of the endothelium in the mouse carotid artery with a flexible wire was described in 1993 23 and allowed the arterial smooth muscle proliferation and/or neointima formation in various transgenic mice to be evaluated. This model of endovascular carotid injury suggested that ER␣ was not involved in one aspect of the protective effect of E 2 , ie, the prevention of medial smooth muscle proliferation. 24 However, the specific evaluation of arterial reendothelialization appears to be difficult with this technique. 23 Recently, Carmeliet et al 25 described a novel model of electric injury to the mouse femoral artery that consisted of destroying endothelial, smooth muscle, and adventitial cells and allowing subsequent quantification of both arterial neointima formation and reendothelialization. 25 We have adapted this model of electric arterial injury to allow the precise study of arterial reendothelialization and to determine which ER subtype was involved in this process.
Our results indicate that the beneficial effect of estrogen on reendothelialization is mediated by ER␣ in female mice.
Methods

Animals
All procedures involving experimental animals were performed in accordance with the recommendations of the French Accreditation of Laboratory Animal Care. They were housed in stainless steel cages in groups of 5, kept in a temperature-controlled facility on a 12-hour light-dark cycle, and fed normal laboratory mouse chow diet.
Targeted disruption (knockout) of mouse ER␣ and ER␤ genes was generated by homologous recombination, resulting in ER␣-and ER␤-null mice. 25a Six backcrosses with C57Bl/6 mice were performed.
For all surgical procedures, mice were anesthetized by injection of 150 mg/kg ketamine IP and allowed to recover on a 37°C heat pack. Mice were ovariectomized at 4 weeks of age and given either 60-day time-release E 2 pellets (0.1 mg E 2 , Innovative Research of America, ie, releasing 80 g ⅐ kg Ϫ1 ⅐ d Ϫ1 ) or placebo-containing pellets implanted subcutaneously into the backs of the animals with a sterile trochar. Electric carotid artery injury was performed 2 weeks later, ie, in 6-week-old mice. Three days after injury, the animals were killed and the vessels harvested.
Electric Injury Model
We adapted the electric injury model described by Carmeliet et al 25 on the femoral artery to the common carotid artery, the latter being easier to dissect. Surgery was carried out with a dissection microscope (Nikon SMZ-2B) in 6-week-old female mice weighing 20 g on average. Because the proximal part of the carotid artery is intrathoracic, the injury could not be applied to the whole common carotid artery. The left common carotid artery was exposed via an anterior incision of the neck. The electric injury (in fact primarily thermal) was applied to the distal part of the common carotid artery. The carotid artery was injured by electric current with a bipolar microregulator. To standardize the temperature increase in the vessel wall, we used forceps with large tips (1 mm) instead of microsurgical forceps (200 m) and a bipolar microregulator Force FX (Valleylab). The "precise" mode of this apparatus allowed delivery of electric energy within a narrow range of resistance, because the generator microprocessor disrupted the electric current when the resistance increased as a consequence of temperature increase. This allowed the increase in tissue temperature to be controlled and avoided the risk of desiccation and coagulation of the arterial wall. The optimal conditions were determined as follows: electric current of 2 W applied for 2 seconds to each millimeter of carotid artery over a total length of 4 mm with the help of a size marker placed parallel to the long axis of the carotid. Despite optimization of the technique, coagulation and thrombosis of the carotid artery occurred in Ϸ10% of the cases, which were then excluded from the study.
One to 7 days later, the endothelial regeneration process was evaluated by staining the denuded areas with Evans blue dye as previously described. 23 Briefly, 50 L of solution containing 5% Evans blue diluted in saline was injected into the tail vein with a 30-gauge needle 10 minutes before euthanization, followed by fixation with a perfusion of 4% phosphate-buffered formalin (pH 7.0) for 5 minutes. Blood, saline, and fixative were removed through an incision in the right atrium. The left common carotid artery was dissected with an adjacent portion of the aortic arch and carotid bifurcation. The artery was then opened longitudinally and placed between slides with Fluoprep. After transparency scanning and numeration, the total and stained carotid artery areas were planimetered with an image analyzer (VISIOL@b2000). The ratio between the area stained in blue and the total carotid artery area was calculated. The surface of the area that remained deendothelialized was indexed to the total carotid artery area to take into account the changes in vessel area due to both the elasticity of the carotid artery and the flattening of the vessel between slides. The coefficients of variation of the endothelial regrowth were 2.6%, 4.5%, and 13.5% at days 1, 3, and 5, respectively ( Figure 1C ).
Histology and Scanning Electron Microscopy
Arteries were also embedded in paraffin, and sections perpendicular to the long axis of the carotid were cut from the proximal, middle, and distal thirds of the injured carotid artery. Sections were subjected to standard hematoxylin and eosin staining.
To verify that the area stained with Evans blue corresponded to the deendothelialized area and that the unstained area corresponded to the reendothelialized area, 3 animals were killed 3 days after the electric injury procedure. Perfusion fixation was carried out as described above with phosphate-buffered 4% paraformaldehyde in vivo. The vessels were cut open longitudinally, pinned flat on a silicone-coated dish, and photographed. The vessels were then further fixed with 2% glutaraldehyde for 24 hours, rinsed with PBS, incubated with 2% osmium tetroxide, and then dehydrated through a series of ethanol dilutions. The tissue was dried to critical point and mounted on scanning electron microscopy stubs with colloidal silver paste. After having been sputter-coated with gold/palladium, the specimens were examined with a scanning electron microscope.
Serum Hormone Concentrations
Radioimmunoassay kits for E 2 were used according to the manufacturer's instructions (Sorin Biomedica). Hormone levels could not be measured in the same mice that were injected with Evans blue because it interfered with the assay. Thus, additional groups of mice were ovariectomized at 4 weeks of age, given either E 2 -or placebocontaining pellets as described above, and killed 17 days later. Hormone levels were assayed for each individual mouse in a similar series of assays. The intra-assay coefficient of variability was 4.5%. The assay sensitivity, defined as 15% displacement of labeled tracer, was 0.5 pg E 2 .
Statistics
Results are expressed as meanϮSEM. To test the respective roles of E 2 treatment and of genotype on reendothelialization, a 2-factor ANOVA was performed (comparison of the 6 groups) in ER␣ and in ER␤ mice. When an interaction was observed between the 2 factors, the effect of E 2 treatment was studied in each genotype with a t test. A value of PϽ0.05 was considered statistically significant.
Results
Generation of the ER␣ and ER␤ Mutant Mice
Heterozygous ER␣-and ER␤-null mice, originally generated as C57Bl/6Jϫ129 hybrids, were crossbred into the C57Bl/6 background to generate the heterozygous ER␣ ϩ/Ϫ and ER␤ ϩ/Ϫ lines, which constituted the population that served as the parental genotypes for all animals in the studies. The offspring of the parental ER␣ ϩ/Ϫ strain were ER␣ ϩ/ϩ , ER␣ ϩ/Ϫ , and ER␣ Ϫ/Ϫ , and those of the parental ER␤ ϩ/Ϫ strain were ER␤ ϩ/ϩ , ER␤ ϩ/Ϫ , and ER␤ Ϫ/Ϫ littermates, respectively, which served as the subjects of our studies.
Description of the Model of Carotid Artery Injury
We first determined the time course of endothelial regeneration (days 1, 3, 5, and 7 after injury) in 6-week-old female C57Bl/6 mice. As shown in Figure 1 , 50% of the endothelial regeneration was observed on days 3 and 4, and complete reendothelialization was observed on day 7. We chose to study reendothelialization on day 3 to evaluate the effect of E 2 . To further ensure that the area stained with Evans blue dye corresponded to a deendothelialized area, electron scanning microscopy studies were performed. These confirmed that the area stained colocalized with an area of endothelial cell denudation and a monolayer of aggregated platelets. A front of migrating endothelial cells was observed at the edges of the lesion (Figure 2A , 2B, and 2C).
Paraffin sections (day 2) with standard staining (hematoxylin/eosin and Masson's trichrome) also demonstrated the absence of endothelial cells (or rare pyknotic nuclei), the absence of smooth muscle cells in the media (or only necrotic fragments), and infiltration of the adventitia by inflammatory cells (Figure 3a and 3b ). Verhoeff staining for elastic lamina revealed that only the most internal lamina was in some cases ruptured (not shown). At day 15, ad integrum restoration of the intima and of the media was observed (Figure 3c and 3d) . However, no neointimal hyperplasia was observed after electric injury of the carotid, even on day 30 (Figure 3e and 3ff). Adventitia was still infiltrated by inflammatory cells, which persisted at day 15 (Figure 3c and 3d ) and at day 30 (Figure 3e and 3f ).
Effect of Estradiol on Endothelial Regeneration
Ovariectomized mice with an implanted placebo pellet showed nondetectable (Ͻ5 pg/mL ie, 20ϫ10 Ϫ12 mol/L) circulating levels of E 2 , whereas those implanted with a pellet releasing 0.1 mg E 2 for 60 days (ie, 80 g ⅐ kg Ϫ1 ⅐ d Ϫ1 ) showed serum E 2 concentrations averaging 0.5ϫ10 Ϫ9 mol/L, irrespective of genotype (Tables 1 and 2) . Ovariectomized, placebotreated mice showed atrophied uteri (Ͻ20 mg); E 2 -treated mice showed a significant increase in uterine weight, except ER␣ Ϫ/Ϫ mice, which had atrophied uteri even when treated with E 2 (Tables 1 and 2) .
Endothelial regeneration was similar in all categories of mice with an implanted placebo pellet, irrespective of genotype (Tables 1 and 2, Figure 4 ). In ER␣-deficient mice, an interaction (Pϭ0.004) between E 2 treatment and genotype on reendothelialization was revealed by the 2-factor ANOVA. In these animals, E 2 treatment significantly accelerated reendothelialization in ER␣ ϩ/ϩ mice (PϽ0.0001), tended to accelerate the reendothelialization in ER␣ ϩ/Ϫ mice (Pϭ0.14), but had no effect in ER␣ Ϫ/Ϫ mice (Pϭ0.95) ( Figure 4 and Table  1 ). In contrast, in ER␤-deficient animals, E 2 treatment significantly accelerated the reendothelialization process in ER␤ ϩ/ϩ , ER␤ ϩ/Ϫ , and ER␤ Ϫ/Ϫ mice in a similar fashion (PϽ0.0001), without influence of genotype (Pϭ0.27, NS). Although the acceleration of the reendothelialization tended to be greater in E 2 -treated ER␤ Ϫ/Ϫ mice treated with E 2 than in ER␤ ϩ/ϩ mice, the difference was not statistically significant, because no interaction between E 2 treatment and the genotype was observed (Pϭ0.73, NS) ( Figure 4 and Table 2 ).
Discussion
Endothelium is both a key actor in the pathophysiology of atherosclerosis and an important target of E 2 in the vessel wall. Indeed, the modulation of several properties of endothelium in response to E 2 could account for the vasculoprotective effect of the hormone. One major function of endothelium is the release of the vasorelaxant and antiaggregant messenger nitric oxide, which is enhanced in oophorectomized females treated with estrogens 26 -28 either directly by upregulation of the endothelial NO synthase gene expression 29 or indirectly by a receptor-mediated antioxidant effect. 30 E 2 was also reported to promote reendothelialization in castrated female rats, 16 but to the best of our knowledge, this effect has not been reported in mice. Moreover, the availabil- ity of genetically modified mice with ER␣ or ER␤ gene disruption offers the possibility of studying the role of each of these ER subtypes in the effect of E 2 on endothelial regeneration. Preliminary experiments led us to modify the model of electric injury initially described by Carmeliet et al 25 to study the reendothelialization process. For technical reasons, we elected to perform the electric injury in the carotid instead of the femoral artery. As reported for the femoral site, 25 we found that the reendothelialization process started immediately after injury and proceeded very actively during the first week after injury. The 4 mm of injured carotid artery was completely reendothelialized within 7 days, ie, 300 m/d for each edge. Taking into account that the average length of an endothelial cell is 50 m (see previous reports 31, 32 and Figure  2 ) and that the doubling time of this cell population is in the range of 24 hours, proliferation would contribute to 50 m/d from each edge over the 7-day period. It would appear from these calculations that reendothelialization relies essentially on local cell migration or circulating endothelial progenitor cells, which have been shown to be incorporated into foci of neovascularization. 33, 34 We observed that E 2 accelerated endothelial regrowth in wild-type mice by 25%, a value close to what had been measured in the rat species. 16 We then sought to determine which ER gene promoted the reendothelialization process. ER␣ has long been considered to be the unique target of E 2 , because it has been characterized in reproductive tissues, in bone, and in vessels, particularly in the endothelial cells. [35] [36] [37] Iafrati et al 24 reported that the prevention of medial enlargement (ie, smooth muscle cell proliferation) by E 2 is preserved in ER␣-deficient mice in a model of endovascular carotid injury. Very recently, the same group reported that E 2 also inhibits medial enlargement in the injured carotid of ER␤deficient mice. 38 It should be underlined that in these studies, vascular smooth muscle cell proliferation was evaluated, whereas in our studies, the effect of E 2 on endothelial regeneration was appreciated. Altogether, these series of data led to the intriguing possibility that reendothelialization could be mediated specifically by the ER␣ gene, whereas arterial smooth muscle cell proliferation could be mediated by a third, as yet unidentified ER gene. Further work should clarify this situation, but taking into account the crucial role of endothelium in the maintenance of vascular integrity, ER␣ should be considered a prime target of pharmacological studies in the area of cardiovascular diseases. 
